HTRN Htetf (MM)

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of HealthTronics, Inc. (“HealthTronics” or the “Company”) (NASDAQ:HTRN) related to the Company’s agreement to be acquired by Endo Pharmaceuticals Holdings Inc. (“Endo”). The proposed transaction is valued at approximately $223 million, including assumed debt.

Under the terms of the definitive merger agreement entered into by the parties, Endo will commence an all-cash tender offer to acquire all of the outstanding shares of HealthTronics common stock for $4.85 per share in cash. The tender offer is expected to commence within 10 business days of May 5, 2010, and will remain open until July 1, 2010, subject to extension under certain circumstances. Upon completion of the tender offer, a wholly owned subsidiary of Endo will merge into HealthTronics and HealthTronics will operate as a wholly owned subsidiary of Endo. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by the HealthTronics board of directors.

If you own shares of HealthTronics, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Htetf (MM) (NASDAQ:HTRN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Htetf (MM) (NASDAQ:HTRN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024